R. Paul Flynn - Sep 9, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP, Global Revenue
Signature
By: Jereme Sylvain For: Paul Flynn
Stock symbol
DXCM
Transactions as of
Sep 9, 2021
Transactions value $
-$756,621
Form type
4
Date filed
9/13/2021, 08:00 PM
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$402K -743 -6.04% $541.36 11.6K Sep 9, 2021 Direct F1, F2
transaction DXCM Common Stock Sale -$4.88K -9 -0.08% $541.76 11.6K Sep 9, 2021 Direct F1, F2
transaction DXCM Common Stock Sale -$350K -626 -5.42% $558.33 10.9K Sep 10, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 Included in this number are 10,928 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
F3 On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.